
Cytotheryx Announces Exclusive License of In Vivo Hepatocyte Selection Technology from OHSU
Cytotheryx secures exclusive license from OHSU for in vivo hepatocyte selection tech to advance safer, scalable therapies for rare and chronic liver diseases. ROCHESTER, MN, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Cytotheryx, Inc., a …